TY - JOUR
KW - DPP-4 inhibitor
KW - SGLT2 inhibitor
KW - Cohort study
KW - diabetes complications
KW - pharmacoepidemiology
KW - Type 2 diabetes
AU - V. van Hulten
AU - J. Driessen
AU - J. Starup-Linde
AU - Z. Al-Mashhadi
AU - R. Viggers
AU - O. Klungel
AU - P. Souverein
AU - P. Vestergaard
AU - C. Stehouwer
AU - J. van den Bergh
AD - Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Steno Diabetes Center North Denmark, Aalborg, Denmark.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
Department of Internal Medicine, Subdivision of Endocrinology, VieCuri Medical Center, Venlo, The Netherlands.
AN - 37503747
BT - Diabetes Obes Metab
DO - 10.1111/dom.15220
DP - NLM
ET - 2023/07/28
LA - eng
N1 - 1463-1326
van Hulten, Veerle
Orcid: 0000-0002-4233-7504
Driessen, Johanna H M
Starup-Linde, Jakob K
Al-Mashhadi, Zheer K
Viggers, Rikke
Klungel, Olaf H
Souverein, Patrick C
Vestergaard, Peter
Stehouwer, Coen D A
Orcid: 0000-0001-8752-3223
van den Bergh, Joop P
Novo Nordisk Steno Collaborative Grant 2018/
Journal Article
England
Diabetes Obes Metab. 2023 Jul 28. doi: 10.1111/dom.15220.
PY - 2023
SN - 1462-8902
T2 - Diabetes Obes Metab
TI - The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus
ER -